| Emerging indocyanine green-integrated nanocarriers for multimodal cancer therapy: a review K Gowsalya, V Yasothamani, R Vivek Nanoscale Advances 3 (12), 3332-3352, 2021 | 50 | 2021 |
| Multifunctional theranostic nanomedicines for cancer treatment: Recent progress and challenges L Karthikeyan, S Sobhana, V Yasothamani, K Gowsalya, R Vivek Biomedical Engineering Advances 5, 100082, 2023 | 11 | 2023 |
| Near-infrared light-activated dual targeting with peptide-conjugated mesoporous silica nanoparticles for multimodal anticancer therapy K Gowsalya, L Karthikeyan, R Vivek ACS Applied Nano Materials 5 (11), 17105-17122, 2022 | 11 | 2022 |
| Engineered photonic near-infrared light activated photothermal theranostic nanovaccine induced targeted remodeling of tumor microenvironment K Gowsalya, B Rithisa, Y Haldorai, K Shanthi, R Vivek Nanomedicine: Nanotechnology, Biology and Medicine 57, 102738, 2024 | 3 | 2024 |
| Recent progress in smart inorganic mesoporous silica-based nanovaccine for cancer B Rithisa, K Gowsalya, PA Rasheed, R Vivek Inorganic Chemistry Communications, 112483, 2024 | | 2024 |
| Immune-theranostic gold nanorod-based NIR-responsive nanomedicine for the delivery of TLR7/8 adjuvant-induced effective anticancer therapy K Gowsalya, B Rithisa, S Shyamsivappan, R Vivek RSC Pharmaceutics, 2024 | | 2024 |
| Inorganic nanoparticle-based nanomedicines for cancer immunotherapy K Gowsalya, L Karthikeyan, R Vivek Nanomedicine in Cancer Immunotherapy, 243-269, 2024 | | 2024 |
| Biomedical Engineering Advances L Karthikeyan, S Sobhana, V Yasothamani, K Gowsalya, R Vivek | | |
